Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6373.0000 -89.50 (-1.38%)
NSE Nov 21, 2025 15:31 PM
Volume: 130.8K
 

6373.00
-1.38%
Axis Direct
While Divis reported 11% YoY decline in Q2 revenue (19% YoY decline in Q1), it exhibited 8% QoQ growth as most plant protocols and procedures (leading to manufacturing disruption) suggested in remediation plan were completed in Q1.
Divi's Laboratories .. has an average target of 6432.50 from 6 brokers.
More from Divi's Laboratories Ltd.
Recommended